Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas”

1,756 pharma patents match "The Board of Regents of the University of Texas" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,756
Index total 30,257
Page 28 / 74

Quick answer

This filtered view shows 1,756 pharmaceutical patents matching "The Board of Regents of the University of Texas" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,756 results for “The Board of Regents of the University of Texas” · 30,257 patents in full index Clear search

  1. US 10279029

    Immunogenic compositions and uses thereof

    The Board of Regents of the University of Texas System · Granted May 7, 2019 · Expires May 2, 2039

    granted

  2. US 10272184

    Hydrogel membrane for adhesion prevention

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  3. US 10272158

    Compounds for treating biofilm infection

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  4. US 10272137

    Compositions and methods relating to myomaker-induced muscle cell fusion

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  5. US 10272084

    Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  6. US 10272099

    Tumor-selective combination therapy

    The Board of Regents of the University of Texas System · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  7. US 10265405

    Polymers for delivery of factor VIII and/or factor IX

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  8. US 10265338

    Compounds and methods for treating neurological and cardiovascular conditions

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  9. US 10267786

    Systems and methods for high-resolution imaging

    The Board of Regents of the University of Texas System · Granted Apr 23, 2019 · Expires Apr 18, 2039

    granted

  10. US 10258631

    Formulations of testosterone and methods of treatment therewith

    The Board of Regents of the University of Texas System · Granted Apr 16, 2019 · Expires Apr 11, 2039

    granted

  11. US 10253424

    Porous particles and methods of making thereof

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  12. US 10251909

    Potassium-magnesium citrate as a surrogate of the DASH diet in managing hypertension

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  13. US 10251398

    Improving shelf life and color profile of resin compositions with silver nanoparticles

    The Board of Regents of the University of Texas System · Granted Apr 9, 2019 · Expires Apr 4, 2039

    granted

  14. US 10240130

    CDNA clone-launched platform for high-yield production of inactivated zika virus

    The Board of Regents of the University of Texas System · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  15. US 10238698

    Biomarkers and combination therapies using oncolytic virus and immunomodulation

    The Board of Regents of the University of Texas System · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  16. US 10238770

    Reparative cell isolation and delivery

    The Board of Regents of the University of Texas System · Granted Mar 26, 2019 · Expires Mar 21, 2039

    granted

  17. US 10231958

    Methods and compositions for enhancing chemotherapy

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  18. US 10233438

    Engineered primate L-methioninase for therapeutic purposes

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  19. US 10231955

    Enhanced delivery of immunosuppressive drug compositions for pulmonary delivery

    The Board of Regents of the University of Texas System · Granted Mar 19, 2019 · Expires Mar 14, 2039

    granted

  20. US 10221235

    Endotrophin neutralization and use thereof

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  21. US 10220078

    Methods of using thrombin derivatives to treat medulloblastoma

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  22. US 10219492

    Compounds and methods for altering RSV replication rate

    The Board of Regents of the University of Texas System · Granted Mar 5, 2019 · Expires Feb 28, 2039

    granted

  23. US 10214529

    Small molecules for the treatment of primary cancer and cancer metastasis

    The Board of Regents of the University of Texas System · Granted Feb 26, 2019 · Expires Feb 21, 2039

    granted

  24. US 10208059

    Heterocyclic modulators of HIF activity for treatment of disease

    The Board of Regents of the University of Texas System · Granted Feb 19, 2019 · Expires Feb 14, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.